Kidtrayze (Zinc Chloride, Potassium Iodide, Sodium Selenite, Copper Chloride Dihydrate, Manganese Chloride Tetr)

The active ingredients provide essential micronutrients that serve as cofactors for numerous enzymes. Zinc, copper and manganese support oxidative‑stress defenses and carbohydrate metabolism, iodine is required for thyroid hormone production, and selenium contributes to antioxidant selenoproteins, collectively restoring normal cellular function.

The dose of Kidtrayze is individualized. A qualified prescriber determines the appropriate volume and concentration based on the patient’s clinical condition, laboratory values and nutritional requirements, following local guidelines and product labeling.

Safety data for Kidtrayze in pregnancy and lactation are limited. It should be used only when the potential therapeutic benefit justifies any possible risk to the fetus or infant, and the decision should be made by the prescribing clinician.

To order Kidtrayze, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and any necessary import documentation.

Kidtrayze combines five essential trace elements in a single intravenous formulation, offering a convenient option for comprehensive supplementation. Compared with single‑element products, it reduces the number of separate infusions needed, but clinicians must still monitor individual element levels to avoid excess or deficiency.

Kidtrayze should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required by the administration protocol.

Kidtrayze is administered intravenously, typically as an infusion added to a compatible carrier solution. The prescribing clinician sets the infusion rate and duration based on the patient’s needs, and administration should be performed by qualified healthcare personnel using aseptic technique.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, significant electrolyte imbalances leading to copper or selenium toxicity, acute renal dysfunction, and cardiovascular instability such as severe hypotension. Prompt recognition and management of these events are essential.

Kidtrayze is contraindicated in patients with known hypersensitivity to any of its components, those with uncontrolled severe electrolyte disturbances, and individuals for whom the risk of trace element overload outweighs the clinical benefit, as determined by the treating physician.